Benefits of long-acting β2-agonists -: Reply

被引：0
|
作者：
Gibson, Peter G. [1 ]
Ducharme, Francine M.
Cates, Christopher Joseph
机构：
[1] John Hunter Hosp, Newcastle, NSW, Australia
[2] McGill Univ, Ctr Hlth, Montreal Childrens Hosp, Montreal, PQ, Canada
[3] St Georges Univ London, London, England
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2007年 / 120卷 / 03期
关键词：
D O I：
10.1016/j.jaci.2007.04.043
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：726 / 726
页数：1
相关论文
共 50 条
  • [31] Safety Profile of long-acting beta 2-Agonists in Patients with Asthma
    Rukavina, Marion
    PNEUMOLOGIE, 2018, 72 (11): : 749 - 749
  • [32] Comparison of bronchodilatory properties of transdermal and inhaled long-acting β2-agonists
    Yamagata, T.
    Hirano, T.
    Sugiura, H.
    Yanagisawa, S.
    Ichikawa, T.
    Ueshima, K.
    Akamatsu, K.
    Nakanishi, M.
    Matsunaga, K.
    Minakata, Y.
    Ichinose, M.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2008, 21 (01) : 160 - 165
  • [33] Should we be afraid of application of long-acting beta 2-agonists?
    Szmidt, Miroslaw
    ALERGIA ASTMA IMMUNOLOGIA, 2008, 13 (04): : 197 - 201
  • [34] Long-Acting β2-Agonists in Asthma: Enantioselective Safety Studies are Needed
    Jacobson, Glenn A.
    Raidal, Sharanne
    Hostrup, Morten
    Calzetta, Luigino
    Wood-Baker, Richard
    Farber, Mark O.
    Page, Clive P.
    Walters, E. Haydn
    DRUG SAFETY, 2018, 41 (05) : 441 - 449
  • [35] Combined analysis of asthma safety trials of long-acting β2-agonists
    Teper, Alejandro
    ARCHIVOS ARGENTINOS DE PEDIATRIA, 2019, 117 (01): : E84 - E86
  • [36] Long-acting β2-agonists in asthma:: an overview of Cochrane systematic reviews
    Walters, JAE
    Wood-Baker, R
    Walters, EH
    RESPIRATORY MEDICINE, 2005, 99 (04) : 384 - 395
  • [37] Roflumilast with long-acting β2-agonists for COPD: influence of exacerbation history
    Bateman, E. D.
    Rabe, K. F.
    Calverley, P. M. A.
    Goehring, U. M.
    Brose, M.
    Bredenbroeker, D.
    Fabbri, L. M.
    EUROPEAN RESPIRATORY JOURNAL, 2011, 38 (03) : 553 - 560
  • [38] Compliance with inhaled glucocorticoids and concomitant use of long-acting β2-agonists
    van der Woude, HJ
    Aalbers, R
    RESPIRATORY MEDICINE, 2001, 95 (05) : 404 - 407
  • [39] Unaltered perception of dyspnoea during treatment with long-acting β2-agonists
    van der Woude, HJ
    Aalbers, R
    EUROPEAN RESPIRATORY JOURNAL, 2001, 18 (02) : 269 - 271
  • [40] Combined Analysis of Asthma Safety Trials of Long-Acting β2-Agonists
    Busse, William W.
    Bateman, Eric D.
    Caplan, Arthur L.
    Kelly, H. William
    O'Byrne, Paul M.
    Rabe, Klaus F.
    Chinchilli, Vernon M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (26): : 2497 - 2505
12345